tetrakis(acetonitrile);bis(1-[3-[[bis[(1-methylimidazol-2-yl)methyl]amino]methyl]pyrazol-1-id-5-yl]-N,N-bis[(1-methylimidazol-2-yl)methyl]methanamine);tetrakis(iron(2+));hexaacetate

C70H96Fe4N28O12 — CID 139182093

IUPACtetrakis(acetonitrile);bis(1-[3-[[bis[(1-methylimidazol-2-yl)methyl]amino]methyl]pyrazol-1-id-5-yl]-N,N-bis[(1-methylimidazol-2-yl)methyl]methanamine);tetrakis(iron(2+));hexaacetate
SMILESCC#N.CC#N.CC#N.CC#N.CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].Cn1ccnc1CN(Cc1cc(CN(Cc2nccn2C)Cc2nccn2C)[n-]n1)Cc1nccn1C.Cn1ccnc1CN(Cc1cc(CN(Cc2nccn2C)Cc2nccn2C)[n-]n1)Cc1nccn1C.[Fe+2].[Fe+2].[Fe+2].[Fe+2]
InChIInChI=1S/2C25H33N12.4C2H3N.6C2H4O2.4Fe/c2*1-32-9-5-26-22(32)16-36(17-23-27-6-10-33(23)2)14-20-13-21(31-30-20)15-37(18-24-28-7-11-34(24)3)19-25-29-8-12-35(25)4;4*1-2-3;6*1-2(3)4;;;;/h2*5-13H,14-19H2,1-4H3;4*1H3;6*1H3,(H,3,4);;;;/q2*-1;;;;;;;;;;;4*+2/p-6
InChIKeyWAKDNHHBGPSZNK-UHFFFAOYSA-H
MW1745.10 g/mol
LogP-2.60
Rot. Bonds24

About tetrakis(acetonitrile);bis(1-[3-[[bis[(1-methylimidazol-2-yl)methyl]amino]methyl]pyrazol-1-id-5-yl]-N,N-bis[(1-methylimidazol-2-yl)methyl]methanamine);tetrakis(iron(2+));hexaacetate

tetrakis(acetonitrile);bis(1-[3-[[bis[(1-methylimidazol-2-yl)methyl]amino]methyl]pyrazol-1-id-5-yl]-N,N-bis[(1-methylimidazol-2-yl)methyl]methanamine);tetrakis(iron(2+));hexaacetate (PubChem CID 139182093) has the molecular formula C70H96Fe4N28O12 and a molecular weight of 1745.10 g/mol. Its IUPAC name is tetrakis(acetonitrile);bis(1-[3-[[bis[(1-methylimidazol-2-yl)methyl]amino]methyl]pyrazol-1-id-5-yl]-N,N-bis[(1-methylimidazol-2-yl)methyl]methanamine);tetrakis(iron(2+));hexaacetate.

Molecular Properties

Compound Nametetrakis(acetonitrile);bis(1-[3-[[bis[(1-methylimidazol-2-yl)methyl]amino]methyl]pyrazol-1-id-5-yl]-N,N-bis[(1-methylimidazol-2-yl)methyl]methanamine);tetrakis(iron(2+));hexaacetate
PubChem CID139182093
Molecular FormulaC70H96Fe4N28O12
Molecular Weight1745.10 g/mol
Exact Mass1744.52
IUPAC Nametetrakis(acetonitrile);bis(1-[3-[[bis[(1-methylimidazol-2-yl)methyl]amino]methyl]pyrazol-1-id-5-yl]-N,N-bis[(1-methylimidazol-2-yl)methyl]methanamine);tetrakis(iron(2+));hexaacetate
SMILESCC#N.CC#N.CC#N.CC#N.CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].Cn1ccnc1CN(Cc1cc(CN(Cc2nccn2C)Cc2nccn2C)[n-]n1)Cc1nccn1C.Cn1ccnc1CN(Cc1cc(CN(Cc2nccn2C)Cc2nccn2C)[n-]n1)Cc1nccn1C.[Fe+2].[Fe+2].[Fe+2].[Fe+2]
InChIInChI=1S/2C25H33N12.4C2H3N.6C2H4O2.4Fe/c2*1-32-9-5-26-22(32)16-36(17-23-27-6-10-33(23)2)14-20-13-21(31-30-20)15-37(18-24-28-7-11-34(24)3)19-25-29-8-12-35(25)4;4*1-2-3;6*1-2(3)4;;;;/h2*5-13H,14-19H2,1-4H3;4*1H3;6*1H3,(H,3,4);;;;/q2*-1;;;;;;;;;;;4*+2/p-6
InChIKeyWAKDNHHBGPSZNK-UHFFFAOYSA-H
XLogP-2.60
TPSA545.44 Ų
H-Bond Donors
H-Bond Acceptors38
Rotatable Bonds24
Heavy Atoms114
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001745.10
LogP ≤ 5-2.60
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1038

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze tetrakis(acetonitrile);bis(1-[3-[[bis[(1-methylimidazol-2-yl)methyl]amino]methyl]pyrazol-1-id-5-yl]-N,N-bis[(1-methylimidazol-2-yl)methyl]methanamine);tetrakis(iron(2+));hexaacetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of tetrakis(acetonitrile);bis(1-[3-[[bis[(1-methylimidazol-2-yl)methyl]amino]methyl]pyrazol-1-id-5-yl]-N,N-bis[(1-methylimidazol-2-yl)methyl]methanamine);tetrakis(iron(2+));hexaacetate?
The IUPAC name of tetrakis(acetonitrile);bis(1-[3-[[bis[(1-methylimidazol-2-yl)methyl]amino]methyl]pyrazol-1-id-5-yl]-N,N-bis[(1-methylimidazol-2-yl)methyl]methanamine);tetrakis(iron(2+));hexaacetate (CID 139182093) is tetrakis(acetonitrile);bis(1-[3-[[bis[(1-methylimidazol-2-yl)methyl]amino]methyl]pyrazol-1-id-5-yl]-N,N-bis[(1-methylimidazol-2-yl)methyl]methanamine);tetrakis(iron(2+));hexaacetate.
What is the SMILES notation for tetrakis(acetonitrile);bis(1-[3-[[bis[(1-methylimidazol-2-yl)methyl]amino]methyl]pyrazol-1-id-5-yl]-N,N-bis[(1-methylimidazol-2-yl)methyl]methanamine);tetrakis(iron(2+));hexaacetate?
The canonical SMILES for tetrakis(acetonitrile);bis(1-[3-[[bis[(1-methylimidazol-2-yl)methyl]amino]methyl]pyrazol-1-id-5-yl]-N,N-bis[(1-methylimidazol-2-yl)methyl]methanamine);tetrakis(iron(2+));hexaacetate is CC#N.CC#N.CC#N.CC#N.CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].Cn1ccnc1CN(Cc1cc(CN(Cc2nccn2C)Cc2nccn2C)[n-]n1)Cc1nccn1C.Cn1ccnc1CN(Cc1cc(CN(Cc2nccn2C)Cc2nccn2C)[n-]n1)Cc1nccn1C.[Fe+2].[Fe+2].[Fe+2].[Fe+2].
What is the InChIKey of tetrakis(acetonitrile);bis(1-[3-[[bis[(1-methylimidazol-2-yl)methyl]amino]methyl]pyrazol-1-id-5-yl]-N,N-bis[(1-methylimidazol-2-yl)methyl]methanamine);tetrakis(iron(2+));hexaacetate?
The InChIKey is WAKDNHHBGPSZNK-UHFFFAOYSA-H. The full InChI is InChI=1S/2C25H33N12.4C2H3N.6C2H4O2.4Fe/c2*1-32-9-5-26-22(32)16-36(17-23-27-6-10-33(23)2)14-20-13-21(31-30-20)15-37(18-24-28-7-11-34(24)3)19-25-29-8-12-35(25)4;4*1-2-3;6*1-2(3)4;;;;/h2*5-13H,14-19H2,1-4H3;4*1H3;6*1H3,(H,3,4);;;;/q2*-1;;;;;;;;;;;4*+2/p-6.
What are the key properties of tetrakis(acetonitrile);bis(1-[3-[[bis[(1-methylimidazol-2-yl)methyl]amino]methyl]pyrazol-1-id-5-yl]-N,N-bis[(1-methylimidazol-2-yl)methyl]methanamine);tetrakis(iron(2+));hexaacetate?
tetrakis(acetonitrile);bis(1-[3-[[bis[(1-methylimidazol-2-yl)methyl]amino]methyl]pyrazol-1-id-5-yl]-N,N-bis[(1-methylimidazol-2-yl)methyl]methanamine);tetrakis(iron(2+));hexaacetate has a molecular weight of 1745.10 g/mol, XLogP of -2.60, 24 rotatable bonds, 0 hydrogen bond donors, and 38 hydrogen bond acceptors.
Where does this data come from?
All data for tetrakis(acetonitrile);bis(1-[3-[[bis[(1-methylimidazol-2-yl)methyl]amino]methyl]pyrazol-1-id-5-yl]-N,N-bis[(1-methylimidazol-2-yl)methyl]methanamine);tetrakis(iron(2+));hexaacetate is sourced from PubChem (CID 139182093), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).